Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
131.09
+0.61 (+0.47%)
Streaming Delayed Price
Updated: 2:24 PM EDT, Jul 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Explore the top gainers and losers within the dow jones index in today's session.
↗
Today 12:40 EDT
Via
Chartmill
Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development
Today 6:45 EDT
From
Merck & Co., Inc.
Via
Business Wire
2 Top Growth Stocks to Buy Right Now Without Any Hesitation
↗
Today 0:50 EDT
There are plenty of reasons to love these companies.
Via
The Motley Fool
Is Pfizer's 7% Dividend Yield Too Good to Be True? Here's the Straight Answer
↗
July 23, 2026
Income seekers shouldn't give up on the stock yet.
Via
The Motley Fool
These dow jones stocks are moving in today's session
↗
July 23, 2026
Via
Chartmill
What's going on in today's session: dow jones movers
↗
July 23, 2026
Via
Chartmill
1 Dow Jones Stock with Exciting Potential and 2 Facing Headwinds
July 23, 2026
While the Dow Jones (^DJI) represents industry leaders, not every stock in the index is a safe bet. Some are facing headwinds like declining demand, rising c...
Via
StockStory
Topics
Artificial Intelligence
Stocks
These dow jones stocks are moving in today's session
↗
July 22, 2026
Via
Chartmill
Stay informed with the top movers within the dow jones index on Tuesday.
↗
July 21, 2026
Via
Chartmill
Which dow jones stocks are moving on Tuesday?
↗
July 21, 2026
Via
Chartmill
Investigational Once-Weekly Oral HIV Treatment Regimen of Islatravir and Lenacapavir Maintained Virological Suppression in Adults With HIV Who Switched Antiretroviral Therapy
July 21, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Merck (NYSE:MRK)
July 20, 2026
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Stay informed with the top movers within the dow jones index on Monday.
↗
July 20, 2026
Via
Chartmill
Uncover the latest developments among dow jones stocks in today's session.
↗
July 20, 2026
Via
Chartmill
These dow jones stocks are moving in today's session
↗
July 17, 2026
Via
Chartmill
Top dow jones movers in Friday's session
↗
July 17, 2026
Via
Chartmill
Which dow jones stocks are moving on Thursday?
↗
July 16, 2026
Via
Chartmill
Merck’s LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia
July 16, 2026
From
Merck & Co., Inc.
Via
Business Wire
What's going on in today's session: dow jones movers
↗
July 15, 2026
Via
Chartmill
Stay informed with the top movers within the dow jones index on Wednesday.
↗
July 15, 2026
Via
Chartmill
Get insights into the top movers in the S&P500 index of Wednesday's pre-market session.
↗
July 15, 2026
Via
Chartmill
Merck to Present New Data on Daily, Weekly, and Monthly Options Across its HIV Treatment and Prevention Pipeline at AIDS 2026
July 15, 2026
From
Merck & Co., Inc.
Via
Business Wire
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy
July 15, 2026
From
Merck & Co., Inc.
Via
Business Wire
Top dow jones movers in Tuesday's session
↗
July 14, 2026
Via
Chartmill
Top dow jones movers in Friday's session
↗
July 10, 2026
Via
Chartmill
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer (MIBC)
July 10, 2026
From
Merck & Co., Inc.
Via
Business Wire
Exploring the top movers within the dow jones index during today's session.
↗
July 10, 2026
Via
Chartmill
Exploring the top movers within the dow jones index during today's session.
↗
July 09, 2026
Via
Chartmill
Stay informed with the top movers within the dow jones index on Wednesday.
↗
July 08, 2026
Via
Chartmill
Exploring the top movers within the dow jones index during today's session.
↗
July 08, 2026
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.